Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FGFR2-AFF4 fusion
i
Other names:
FGFR2, BEK, CD332, CEK3, CFD1, ECT1, JWS, K-SAM, KGFR, TK14, TK25, Fibroblast growth factor receptor 2, AFF4, AF4/FMR2 Family Member 4, Major CDK9 Elongation Factor-Associated Protein, ALL1-Fused Gene From Chromosome 5q31 Protein, AF5Q31, MCEF, ALL1 Fused Gene From 5q31, AF4/FMR2 Family, Member 4, Protein AF-5q31
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2263
;
27125
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
BAP1 mutation + FGFR2 fusion (1)
FGFR2 underexpression + FGFR3 mutation (1)
IDH1 mutation + FGFR2 fusion (1)
IDH1 mutation + FGFR2 rearrangement (1)
NOTCH1 positive + FGFR2 mutation (1)
PBRM1 mutation + FGFR2 fusion (1)
TP53 mutation + FGFR2 fusion (1)
MLL-AF4 fusion (1)
FGFR2 K660N + TP53 deletion (0)
BAP1 mutation + FGFR2 fusion (1)
FGFR2 underexpression + FGFR3 mutation (1)
IDH1 mutation + FGFR2 fusion (1)
IDH1 mutation + FGFR2 rearrangement (1)
NOTCH1 positive + FGFR2 mutation (1)
PBRM1 mutation + FGFR2 fusion (1)
TP53 mutation + FGFR2 fusion (1)
MLL-AF4 fusion (1)
FGFR2 K660N + TP53 deletion (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FGFR2-AFF4 fusion
Cholangiocarcinoma
FGFR2-AFF4 fusion
Cholangiocarcinoma
pemigatinib + TP-0903
Sensitive: D – Preclinical
pemigatinib + TP-0903
Sensitive
:
D
pemigatinib + TP-0903
Sensitive: D – Preclinical
pemigatinib + TP-0903
Sensitive
:
D
FGFR2-AFF4 fusion
Cholangiocarcinoma
FGFR2-AFF4 fusion
Cholangiocarcinoma
pemigatinib + BGB324
Sensitive: D – Preclinical
pemigatinib + BGB324
Sensitive
:
D
pemigatinib + BGB324
Sensitive: D – Preclinical
pemigatinib + BGB324
Sensitive
:
D
FGFR2-AFF4 fusion
Cholangiocarcinoma
FGFR2-AFF4 fusion
Cholangiocarcinoma
TP-0903
Sensitive: D – Preclinical
TP-0903
Sensitive
:
D
TP-0903
Sensitive: D – Preclinical
TP-0903
Sensitive
:
D
FGFR2-AFF4 fusion
Cholangiocarcinoma
FGFR2-AFF4 fusion
Cholangiocarcinoma
BGB324
Sensitive: D – Preclinical
BGB324
Sensitive
:
D
BGB324
Sensitive: D – Preclinical
BGB324
Sensitive
:
D
FGFR2-AFF4 fusion
Cholangiocarcinoma
FGFR2-AFF4 fusion
Cholangiocarcinoma
pemigatinib
Resistant: D – Preclinical
pemigatinib
Resistant
:
D
pemigatinib
Resistant: D – Preclinical
pemigatinib
Resistant
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.